Non Muscle Invasive Bladder Cancer Market to Soar on Novel Immunotherapy Advances
The Non Muscle Invasive Bladder Cancer Market encompasses a range of diagnostics and therapeutic products designed to detect and treat early-stage bladder tumors that have not penetrated the muscular layer. Key product segments include intravesical therapies such as Bacillus Calmette-Guérin (BCG), chemotherapy agents like mitomycin C, and emerging immunotherapies and checkpoint...
0 Commentarios 0 Acciones 554 Views 0 Vista previa